Background It is recommended that all pregnant women be offered screening for Down
syndrome and open neural tube defects, but emerging prenatal tests that are not publicly …

Objective To compile current usage of serum-based prenatal screening for Down syndrome
in the United States and compare it with results from a similar 2011/2012 survey. Setting The …

Antenatal screening and diagnostic testing for Down syndrome has greatly advanced over
the past 30 years. The goal of this manuscript is to provide a review of the availability and …

Abstract Objective Non‐Invasive Prenatal Testing (NIPT) is increasingly being implemented
worldwide. In public health programs, equitable access to healthcare is a fundamental …

Objectives To map prenatal screening and diagnostic testing pathways in Victorian pregnant
women during 2003 to 2004; measure the impact of prenatal diagnostic testing uptake on …

Non-invasive prenatal testing (NIPT) during pregnancy is a highly sensitive and specific
screening tool for chromosomal aneuploidy. This screening has the highest detection rate …

Objective To compare offer and uptake of prenatal screening for Down syndrome in women
from different social and ethnic backgrounds. Method A total of 4800 randomly selected …

Objective To investigate the benefits and costs of implementing non-invasive prenatal
testing (NIPT) for Down's syndrome into the NHS maternity care pathway. Design …

Introduction: Since the early 1980s, prenatal screening using ultrasound and biochemical
markers has been used to refine the risk of Down syndrome and other fetal anomalies prior …

OBJECTIVE: To identify predictors of prenatal genetic testing decisions and explore whether
racial or ethnic and socioeconomic differences are explained by knowledge, attitudes, and …